Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1991
03/21/1991WO1991003553A1 TUMOR NECROSIS FACTOR-α AND -β RECEPTORS
03/21/1991WO1991003544A1 Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
03/21/1991WO1991003493A1 Bi-or trispecific (fab)3 or (fab)4 conjugates
03/21/1991WO1991003490A1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide
03/21/1991WO1991003254A1 Wound healing
03/21/1991WO1991003252A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
03/21/1991WO1991003251A1 Cr2 ligand compositions and methods for modulating immune cell functions
03/21/1991WO1991003233A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
03/21/1991WO1991003162A1 Chimeric dna-rna catalytic sequences
03/21/1991DE3930510A1 Verfahren zur inaktivierung von viren in blut und blutprodukten A method for inactivation of viruses in blood and blood products
03/21/1991CA2485553A1 Tumor necrosis factor - .alpha. and - .beta. receptors
03/21/1991CA2025743A1 Plasminogen activator derivative and a method for its manufacture
03/20/1991WO1991004336A1 Method for improving human monoclonal antibody production
03/20/1991EP0418014A1 Tumor necrosis factor-alpha and -beta receptors
03/20/1991EP0417930A1 Low-irritative nasal preparation
03/20/1991EP0417927A1 Detection and treatment of infections with immunoconjugates
03/20/1991EP0417819A1 Psycho-pharmacological peptides
03/20/1991EP0417818A1 Selecting amounts of platelet releasate for efficacious treatment of tissue
03/20/1991EP0417803A1 [N-(gamma-glutamyl)glycyl] alanine derivatives
03/20/1991EP0417743A1 Cleavage promoter
03/20/1991EP0417725A2 Bile-acid derivatives, a process for their production and their use as medicines
03/20/1991EP0417721A2 Novel peptidase and isomerase inhibitors
03/20/1991EP0417563A2 TNF-binding proteins
03/20/1991EP0417473A1 Treatment of cardiac and also vascular hypertrophy and hyperplasia
03/20/1991EP0417454A2 Reduced size LHRH analogs
03/20/1991EP0417271A1 Diagnosis and treatment of insulin dependent diabetes mellitus
03/20/1991EP0417217A1 Peptides with sulphate ester groups
03/20/1991EP0417168A1 Antibodies to human mammary cell growth inhibitor and methods of production and use
03/20/1991EP0417165A1 Polypeptide compounds having growth hormone releasing activity.
03/20/1991EP0341264A4 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
03/20/1991CA2066720A1 Method for improving human monoclonal antibody production
03/19/1991US5001225 Monoclonal antibodies to a pan-malarial antigen
03/19/1991US5001223 Parathyroid hormone antagonists with enhanced metabolic properties
03/19/1991US5001222 Des-17-histidine-calcitonin
03/19/1991US5001169 Inductive collagen-based bone repair preparations
03/19/1991US5001112 Antitumor antibiotic kedarcidin
03/19/1991US5001057 Truncated human IL-1 cDNA sequences which encode biologically-active human IL-1 proteins
03/19/1991US5000953 Biologically active substance
03/19/1991US5000952 Polypeptide pertussis toxin vaccine
03/19/1991US5000936 Methods for locally-treating allergic disorders with pharmaceutical preparations containing N-acetyl-aspartyl glutamic acid or its salts
03/19/1991CA2025577A1 Anticoagulant and antihelminthic proteins and methods for the production and use of same
03/19/1991CA1281850C Process for producing novel crystals of n _ -¬¬(s)-4-oxo-2-azetidinyl|-carbonyl|-l-histidyl-l- prolinamide
03/19/1991CA1281647C Compositions and methods for the treatment of bleeding disorders
03/19/1991CA1281646C Recombinant interleukin-2 composition and process for making it
03/19/1991CA1281645C Pharmaceutical composition containing proteinaceous materials
03/16/1991WO1991004316A2 Ciliary neurotrophic factor
03/16/1991WO1991004262A1 New hcv isolates
03/16/1991WO1991004046A1 Gamma glutamyl transferases for treating diseases
03/16/1991WO1991004040A1 Treatment of colon cancer
03/16/1991WO1991004035A1 Selecting amounts of platelet releasate for efficacious treatment of tissue
03/16/1991CA2066588A1 Selecting amounts of platelet releasate for efficacious treatment of tissue
03/16/1991CA2065157A1 Gamma glutamyl transferases for treating diseases
03/16/1991CA2042027A1 Treatment of colon cancer
03/16/1991CA2040404A1 Ciliary neurotrophic factor
03/15/1991WO1991004268A1 [N-(η-GLUTAMYL)GLYCYL]ALANINE DERIVATIVES
03/15/1991WO1991004050A1 Therapeutic compositions; methods for treatment of hiv infections
03/15/1991CA2065029A1 Therapeutic compositions; methods for treatment of hiv infections
03/15/1991CA2035458A1 ¬n-(û-glutamyl)glycyl|alanine derivatives
03/14/1991WO1991003933A1 Process for inactivating viruses in blood and blood products
03/13/1991WO1991004320A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man
03/13/1991EP0417002A1 Application of globin hydrolisates for cell stimulation, activity test for these substances, pharmaceutical and cosmetic products and process for the preparation of globin hydrolysates
03/13/1991EP0416983A1 Process for the preparation of a concentrate from factor VIII-factor von Willebrand of blood coagulation from the whole plasma
03/13/1991EP0416743A1 Antivirale Verwendung von Zusammensetzungen bestehend aus EFAs und Interferon
03/13/1991EP0416740A2 Novel compounds with renin-inhibiting activity
03/13/1991EP0416652A2 Interferon-gamma receptor fragment and its production
03/13/1991EP0416578A2 Protein, DNA and use thereof
03/13/1991EP0416575A2 Drug delivery compositions based on biological materials and methods for preparing such compositions
03/13/1991EP0416393A1 Peptidyl difluorodiol renin inhibitors
03/13/1991EP0416373A2 Amino acid derivatives
03/13/1991EP0416108A1 Nutritious composition
03/13/1991EP0416029A1 Procalcitonin peptides
03/13/1991EP0415999A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits
03/13/1991EP0415981A1 Retroviral protease inhibitors
03/13/1991EP0415929A1 Heteroligating antibodies and therapeutic uses thereof
03/13/1991EP0415924A1 Regulation of cell proliferation and differentiation using peptides.
03/13/1991EP0394326A4 Conformationally stabilized cell adhesion peptides
03/13/1991EP0379534A4 Method of purifying cross-linked hemoglobin
03/13/1991EP0185762B1 Cell-delivery agent
03/13/1991CN1049865A Plasminogen activator complex of pure prourokinase covalently bound by disulfide bridge to human serum albumin
03/13/1991CA2065454A1 Use of thioredoxin in the treatment of malignantly transformed cells in animals and man
03/13/1991CA2019878A1 Method of treatment of rheumatoid arthritis using phytic acid
03/12/1991WO1991004267A1 A method for the purification of transforming growth factor (tgf-)
03/12/1991WO1991003491A1 TGF-β PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION
03/12/1991US4999370 Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
03/12/1991US4999349 BU-4164E - A and B, prolyl endopeptidase inhibitors
03/12/1991US4999339 Combination therapy of IL-2 and DTIC for the treatment of melanoma
03/12/1991US4999291 Production of human pluripotent granulocyte colony-stimulating factor
03/12/1991US4999194 Two-chain urokinase plasminogen activators for treatment of thrombotic disease
03/12/1991US4999192 Novel coleopteran-active bacillus thuringiensis isolate
03/12/1991CA2066576A1 Method and apparatus for the production of tgf-beta and purified tgf-beta compositions
03/12/1991CA2066228A1 Tgf-beta protein compositions for inhibition of cell proliferation
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/12/1991CA1281330C2 Intermediates for the preparation of n-alkylated dipeptides and their esters
03/12/1991CA1281286C Oxytocin and antigestagen for induction of birth
03/09/1991WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas
03/09/1991WO1991003253A1 Treatment of insulin-resistant diabetes
03/09/1991CA2066227A1 Insulin-resistant diabetes
03/08/1991WO1991003555A1 Interleukin-4 receptors
03/08/1991WO1991003259A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
03/08/1991CA2066244A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
1 ... 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 ... 3163